Effect of Digital Storytelling Intervention on Diabetes Self-Management in Pregnant Women With Gestational Diabetes
Launched by IZMIR KATIP CELEBI UNIVERSITY · Nov 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how digital storytelling can help pregnant women manage their gestational diabetes. Gestational diabetes is a type of diabetes that can develop during pregnancy and requires careful management to ensure the health of both the mother and the baby. In this study, researchers want to see if sharing and listening to personal stories through digital media can improve how women feel about managing their diabetes and their confidence in handling their condition.
To participate in this trial, women must be at least 18 years old, diagnosed with gestational diabetes, and between 24 to 32 weeks pregnant. They also need to have a treatment plan in place, be able to read and write in Turkish, and own a smartphone. Participants will share their experiences and learn from each other, which may help them feel more empowered in managing their diabetes. It's important to note that those with other pregnancy complications or who are unable to attend follow-up appointments may not be eligible.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Being 18 years or older
- • Being diagnosed with Gestational Diabetes
- • 24-32. being between weeks of pregnancy
- • Having a treatment plan made after gestational diabetes diagnosis
- • Volunteering to participate in the study
- • Knowing how to read and write Turkish
- • Not having any pregnancy complications other than Gestational Diabetes
- • Having a smart phone
- Exclusion Criteria:
- • -Pregnant women who do not meet the inclusion criteria will be excluded from the study. Moreover; Pregnant women whose blood sugar monitoring was terminated by the doctor during the follow-up, who did not continue hospital checks during the research period or could not be reached, and who experienced preterm labor before the end of the follow-up will be excluded from the study.
About Izmir Katip Celebi University
Izmir Katip Celebi University is a prominent academic institution in Turkey, dedicated to advancing medical research and education. The university is committed to fostering innovation and excellence in clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of experienced researchers and healthcare professionals. With a focus on improving patient outcomes and contributing to the global body of medical knowledge, Izmir Katip Celebi University actively engages in collaborative research initiatives, aiming to address critical health challenges through rigorous scientific inquiry and ethical practices in clinical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cigli, İzmir, Turkey
Cigli, , Turkey
Patients applied
Trial Officials
Gülşen Işık
Principal Investigator
Izmir Katip Celebi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported